• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
P2X and P2Y receptors—role in the pathophysiology of the nervous system.P2X和P2Y受体——在神经系统病理生理学中的作用
Int J Mol Sci. 2014 Dec 18;15(12):23672-704. doi: 10.3390/ijms151223672.
2
Purinergic signaling and the functioning of the nervous system cells.嘌呤能信号传导与神经系统细胞的功能
Cell Mol Biol Lett. 2015 Dec;20(5):867-918. doi: 10.1515/cmble-2015-0050.
3
Medicinal chemistry of adenosine, P2Y and P2X receptors.腺苷、P2Y 和 P2X 受体的药物化学
Neuropharmacology. 2016 May;104:31-49. doi: 10.1016/j.neuropharm.2015.12.001. Epub 2015 Dec 12.
4
The therapeutic potential of purinergic signalling.嘌呤能信号转导的治疗潜力。
Biochem Pharmacol. 2018 May;151:157-165. doi: 10.1016/j.bcp.2017.07.016. Epub 2017 Jul 21.
5
Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages.嘌呤能受体激动剂调节巨噬细胞吞噬和清除凋亡细胞。
Immunobiology. 2011 Jan-Feb;216(1-2):1-11. doi: 10.1016/j.imbio.2010.03.010. Epub 2010 Apr 9.
6
The P2Y/P2X divide: How it began.P2Y/P2X 分野:起源
Biochem Pharmacol. 2021 May;187:114408. doi: 10.1016/j.bcp.2021.114408. Epub 2021 Jan 11.
7
P2X and P2Y nucleotide receptors as targets in cardiovascular disease.P2X 和 P2Y 核苷酸受体作为心血管疾病的靶点。
Future Med Chem. 2013 Mar;5(4):431-49. doi: 10.4155/fmc.13.6.
8
Purinergic system, microglia and neuropathic pain.嘌呤能系统、小胶质细胞与神经病理性疼痛。
Curr Opin Pharmacol. 2012 Feb;12(1):74-9. doi: 10.1016/j.coph.2011.10.014. Epub 2011 Oct 27.
9
Purinergic receptors in embryonic and adult neurogenesis.胚胎和成体神经发生中的嘌呤能受体
Neuropharmacology. 2016 May;104:272-81. doi: 10.1016/j.neuropharm.2015.10.008. Epub 2015 Oct 9.
10
Signalling by extracellular nucleotides in health and disease.细胞外核苷酸在健康和疾病中的信号传递。
Biochim Biophys Acta Mol Cell Res. 2022 May;1869(5):119237. doi: 10.1016/j.bbamcr.2022.119237. Epub 2022 Feb 9.

引用本文的文献

1
Extracellular Vesicles and Purinergic Signaling in Alzheimer's Disease-Joining Forces for Novel Therapeutic Approach.阿尔茨海默病中的细胞外囊泡与嘌呤能信号传导——携手探索新型治疗方法
Brain Sci. 2025 May 26;15(6):570. doi: 10.3390/brainsci15060570.
2
Mitochondrial damage-associated molecular patterns: Neuroimmunomodulators in central nervous system pathophysiology.线粒体损伤相关分子模式:中枢神经系统病理生理学中的神经免疫调节剂
Neural Regen Res. 2025 Jun 19. doi: 10.4103/NRR.NRR-D-24-01459.
3
The Ectonucleotidases CD39 and CD73 and the Purinergic Receptor P2X4 Serve as Prognostic Markers in Non-Small Cell Lung Cancer.外核苷酸酶CD39和CD73以及嘌呤能受体P2X4作为非小细胞肺癌的预后标志物。
Cancers (Basel). 2025 Mar 28;17(7):1142. doi: 10.3390/cancers17071142.
4
Recombinant-Chemosynthetic Biosensors for Probing Cell Surface Signaling of Red Blood Cells and Other Cells.用于探测红细胞和其他细胞表面信号传导的重组化学合成生物传感器
Chem Biomed Imaging. 2025 Jan 3;3(2):95-110. doi: 10.1021/cbmi.4c00067. eCollection 2025 Feb 24.
5
Global trends of purinergic receptors and depression: A bibliometric analysis from 2003 to 2023.嘌呤能受体与抑郁症的全球趋势:2003年至2023年的文献计量分析
World J Psychiatry. 2025 Feb 19;15(2):102344. doi: 10.5498/wjp.v15.i2.102344.
6
Purines and purinergic receptors in primary tumors of the central nervous system.中枢神经系统原发性肿瘤中的嘌呤与嘌呤能受体
Purinergic Signal. 2024 Oct 1. doi: 10.1007/s11302-024-10053-8.
7
Functional Role of Piezo1 in the Human Eosinophil Cell Line AML14.3D10: Implications for the Immune and Sensory Nervous Systems.Piezo1 在人嗜酸性粒细胞细胞系 AML14.3D10 中的功能作用:对免疫和感觉神经系统的影响。
Biomolecules. 2024 Sep 14;14(9):1157. doi: 10.3390/biom14091157.
8
Receptors Involved in COVID-19-Related Anosmia: An Update on the Pathophysiology and the Mechanistic Aspects.与 COVID-19 相关的嗅觉丧失的受体:病理生理学和机制方面的最新进展。
Int J Mol Sci. 2024 Aug 5;25(15):8527. doi: 10.3390/ijms25158527.
9
P2X7 Receptor-Induced Human Mast Cell Degranulation Is Enhanced by Interleukin 33.P2X7 受体诱导的人肥大细胞脱颗粒作用可被白细胞介素 33 增强。
Int J Mol Sci. 2024 Jan 31;25(3):1730. doi: 10.3390/ijms25031730.
10
Age-Dependent Activation of Pannexin1 Function Contributes to the Development of Epileptogenesis in Autosomal Dominant Sleep-related Hypermotor Epilepsy Model Rats.年龄依赖性的 Pannexin1 功能激活有助于常染色体显性遗传性睡眠相关运动性癫痫模型大鼠癫痫发生的发展。
Int J Mol Sci. 2024 Jan 28;25(3):1619. doi: 10.3390/ijms25031619.

本文引用的文献

1
P2Y(12) receptor on the verge of a neuroinflammatory breakdown.P2Y(12)受体处于神经炎症崩溃的边缘。
Mediators Inflamm. 2014;2014:975849. doi: 10.1155/2014/975849. Epub 2014 Aug 7.
2
Lack of effect of a P2Y6 receptor antagonist on neuropathic pain behavior in mice.P2Y6受体拮抗剂对小鼠神经性疼痛行为无影响。
Pharmacol Biochem Behav. 2014 Sep;124:389-95. doi: 10.1016/j.pbb.2014.07.009. Epub 2014 Jul 18.
3
Role of spinal P2Y6 and P2Y11 receptors in neuropathic pain in rats: possible involvement of glial cells.脊髓 P2Y6 和 P2Y11 受体在大鼠神经病理性疼痛中的作用:胶质细胞的可能参与。
Mol Pain. 2014 May 20;10:29. doi: 10.1186/1744-8069-10-29.
4
ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment.ATP/P2X7轴调节神经母细胞瘤微环境中髓源性抑制细胞的功能。
Cell Death Dis. 2014 Mar 20;5(3):e1135. doi: 10.1038/cddis.2014.109.
5
Inhibition of G protein-coupled P2Y2 receptor induced analgesia in a rat model of trigeminal neuropathic pain.G 蛋白偶联 P2Y2 受体抑制在大鼠三叉神经病理性疼痛模型中的镇痛作用。
Mol Pain. 2014 Mar 18;10:21. doi: 10.1186/1744-8069-10-21.
6
The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis.P2X7受体拮抗剂亮蓝G通过联合控制突触毒性、神经毒性和胶质细胞增生,减轻帕金森病大鼠模型的对侧旋转。
Neuropharmacology. 2014 Jun;81:142-52. doi: 10.1016/j.neuropharm.2014.01.045. Epub 2014 Feb 6.
7
P2X receptors in neuroglia.神经胶质细胞中的P2X受体
Wiley Interdiscip Rev Membr Transp Signal. 2012;1(2). doi: 10.1002/wmts.12.
8
P2X receptors as targets for the treatment of status epilepticus.P2X 受体作为治疗癫痫持续状态的靶点。
Front Cell Neurosci. 2013 Nov 26;7:237. doi: 10.3389/fncel.2013.00237.
9
P2X4 receptors control the fate and survival of activated microglia.P2X4 受体控制激活的小胶质细胞的命运和存活。
Glia. 2014 Feb;62(2):171-84. doi: 10.1002/glia.22596. Epub 2013 Nov 19.
10
So depression is an inflammatory disease, but where does the inflammation come from?那么抑郁症就是一种炎症性疾病,但炎症从何而来呢?
BMC Med. 2013 Sep 12;11:200. doi: 10.1186/1741-7015-11-200.

P2X和P2Y受体——在神经系统病理生理学中的作用

P2X and P2Y receptors—role in the pathophysiology of the nervous system.

作者信息

Puchałowicz Kamila, Tarnowski Maciej, Baranowska-Bosiacka Irena, Chlubek Dariusz, Dziedziejko Violetta

机构信息

Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, 72 Powstańców Wielkopolskich Street, Szczecin 70-111, Poland.

Department of Physiology, Pomeranian Medical University, 72 Powstańców Wielkopolskich Street, Szczecin 70-111, Poland.

出版信息

Int J Mol Sci. 2014 Dec 18;15(12):23672-704. doi: 10.3390/ijms151223672.

DOI:10.3390/ijms151223672
PMID:25530618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4284787/
Abstract

Purinergic signalling plays a crucial role in proper functioning of the nervous system. Mechanisms depending on extracellular nucleotides and their P2 receptors also underlie a number of nervous system dysfunctions. This review aims to present the role of purinergic signalling, with particular focus devoted to role of P2 family receptors, in epilepsy, depression, neuropathic pain, nervous system neoplasms, such as glioma and neuroblastoma, neurodegenerative diseases like Parkinson's disease, Alzheimer's disease and multiple sclerosis. The above-mentioned conditions are associated with changes in expression of extracellular ectonucleotidases, P2X and P2Y receptors in neurons and glial cells, as well as releasing considerable amounts of nucleotides from activated or damaged nervous tissue cells into the extracellular space, which contributes to disturbance in purinergic signalling. The numerous studies indicate a potential possibility of using synthetic agonists/antagonists of P2 receptors in treatment of selected nervous system diseases. This is of particular significance, since numerous available agents reveal a low effectiveness and often produce side effects.

摘要

嘌呤能信号传导在神经系统的正常功能中起着至关重要的作用。依赖细胞外核苷酸及其P2受体的机制也是许多神经系统功能障碍的基础。本综述旨在阐述嘌呤能信号传导的作用,特别关注P2家族受体在癫痫、抑郁症、神经性疼痛、神经系统肿瘤(如胶质瘤和神经母细胞瘤)、神经退行性疾病(如帕金森病、阿尔茨海默病和多发性硬化症)中的作用。上述疾病与神经元和神经胶质细胞中细胞外核苷酸酶、P2X和P2Y受体表达的变化有关,以及从活化或受损的神经组织细胞中释放大量核苷酸到细胞外空间,这导致嘌呤能信号传导紊乱。众多研究表明,使用P2受体的合成激动剂/拮抗剂治疗某些神经系统疾病具有潜在可能性。这具有特别重要的意义,因为许多现有药物疗效不佳且往往会产生副作用。